Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation Associated With Alzheimer's Disease Dementia”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Looking for participantsNCT07284472
What this trial is testing

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH 300
Large-scale testing (Phase 3)Looking for participantsNCT06937229
What this trial is testing

Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Who this might be right for
Alzheimer DiseaseAgitation
Bristol-Myers Squibb 650
Not applicableNot Yet RecruitingNCT06495957
What this trial is testing

Electroacupuncture for the Treatment of Agitated Symptoms of Alzheimer's Disease

Who this might be right for
Agitation Associated With Alzheimer's DementiaAlzheimer's Dementia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 224
Large-scale testing (Phase 3)Study completedNCT00621647
What this trial is testing

Seroquel- Agitation Associated With Dementia

Who this might be right for
Alzheimer's DiseaseVascular Dementia
AstraZeneca 333
Large-scale testing (Phase 3)Looking for participantsNCT07011745
What this trial is testing

Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 426
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Large-scale testing (Phase 3)Study completedNCT03620981
What this trial is testing

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 410
Large-scale testing (Phase 3)Study completedNCT03724942
What this trial is testing

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 164
Early research (Phase 1)Study completedNCT06546995
What this trial is testing

Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseHealthy Elderly
Neumora Therapeutics, Inc. 87
Large-scale testing (Phase 3)Study completedNCT03548584
What this trial is testing

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Alzheimer's DementiaAlzheimer Dementia
Otsuka Pharmaceutical Development & Commercialization, Inc. 345
Large-scale testing (Phase 3)Study completedNCT03594123
What this trial is testing

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 259
Testing effectiveness (Phase 2)Looking for participantsNCT06052254
What this trial is testing

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation
Teikoku Pharma USA, Inc. 150
Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Looking for participantsNCT06947941
What this trial is testing

Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Who this might be right for
Alzheimer DiseasePsychosis
Bristol-Myers Squibb 325
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Not applicableStudy completedNCT02192554
What this trial is testing

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Who this might be right for
Agitation Associated With Alzheimer's DiseaseAlzheimer's TypeMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 450
Testing effectiveness (Phase 2)Looking for participantsNCT06803823
What this trial is testing

ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Ono Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Looking for participantsNCT07011732
What this trial is testing

Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 426
Testing effectiveness (Phase 2)Looking for participantsNCT06651567
What this trial is testing

Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Who this might be right for
Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc. 320